Luke Boulter

8.6k citations

48 papers · 3.7k indexed · 4 hit papers · h-index 22

Hepatology top 0.5%
Surgery top 2%
Molecular Biology top 10%
Epidemiology top 2%
Immunology top 5%

Co-authors: Stuart J. Forbes John P. Iredale Wei‐Yu Lu Owen J. Sansom Nico van Rooijen Thomas G. Bird Antonella Pellicoro Prakash Ramachandran
Topics: Liver physiology and pathology (22 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers)Pediatric Hepatobiliary Diseases and Treatments (10 papers)
Cited by: Hepatology Surgery Immunology
Journals: Nature Proceedings of the National Academy of Sciences The Lancet
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Luke Boulter

46 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

2012 757 citations Prakash Ramachandran, Antonella Pellicoro et al. Proceedings of the National Academy of Sciences profile →
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease

2012 582 citations Luke Boulter, Olivier Govaere et al. Nature Medicine profile →
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

2017 381 citations Alexander Raven, Wei‐Yu Lu et al. profile →
Hepatic progenitor cells of biliary origin with liver repopulation capacity

2015 345 citations Wei‐Yu Lu, Thomas G. Bird et al. Nature Cell Biology profile →

Peers

Countries citing papers authored by Luke Boulter

Since Specialization

Citations

This map shows the geographic impact of Luke Boulter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Boulter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Boulter more than expected).

Fields of papers citing papers by Luke Boulter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Boulter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Boulter. The network helps show where Luke Boulter may publish in the future.

Co-authorship network of co-authors of Luke Boulter

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Boulter. A scholar is included among the top collaborators of Luke Boulter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Boulter. Luke Boulter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma 2025 ·Scientific Reports ·(unknown),(unknown),Apinya Jusakul,Nisana Namwat,Poramate Klanrit,Hasaya Dokduang,(unknown),Attapol Titapun,(unknown),(unknown),(unknown),Bin Tean Teh,Luke Boulter,Yoshinori Murakami,Watcharin Loilome	2
2	Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma 2025 ·Scientific Reports ·(unknown),Sittiruk Roytrakul,(unknown),Nisana Namwat,Poramate Klanrit,Hasaya Dokduang,(unknown),(unknown),(unknown),(unknown),(unknown),Luke Boulter,Watcharin Loilome	1
3	Primary cilia as a targetable node between biliary injury, senescence and regeneration in liver transplantation 2024 ·Journal of Hepatology ·Hannah Esser,Alastair M. Kilpatrick,Tak Yung Man,Rhona Aird,Daniel Rodrigo‐Torres,(unknown),Luke Boulter,Sarah R. Walmsley,Gabriel C. Oniscu,Stefan Schneeberger,Sofía Ferreira-González,Stuart J. Forbes	11
4	NOTCH signalling – a core regulator of bile duct disease? 2023 ·Disease Models & Mechanisms ·(unknown),Luke Boulter	4
5	A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 2023 ·Science Translational Medicine ·(unknown),Yuelin Yao,Paula Olaizola,Alexander Walker,Edward J. Jarman,(unknown),(unknown),(unknown),Philippe Gautier,(unknown),Massimiliano Cadamuro,Luca Fabris,Joost P.H. Drenth,Timothy J. Kendall,Jesús M. Bañales,Ava Khamseh,Pleasantine Mill,Luke Boulter	9
6	Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing 2023 ·EBioMedicine ·(unknown),(unknown),(unknown),Nicola Harris,(unknown),(unknown),Rosa Miquel,Yoh Zen,Ane Zamalloa,Farooq Malik,Andreas Prachalias,Krishna Menon,Luke Boulter,Simon Eaton,Nigel Heaton,S M Phillips,Shilpa Chokshi,Elena Palma	16
7	In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma 2022 ·Cancer Research ·(unknown),(unknown),(unknown),Edward J. Jarman,Alison Meynert,Graeme R. Grimes,(unknown),(unknown),Peter A. Tennant,David H. Wilson,Rachel V. Guest,Stephen J. Wigmore,Juan Carlos Acosta,Timothy J. Kendall,Martin S. Taylor,Duncan Sproul,Pleasantine Mill,Luke Boulter	7
8	DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN ‐01 2022 ·Liver International ·Edward J. Jarman,(unknown),(unknown),(unknown),(unknown),Daniel Soong,(unknown),(unknown),(unknown),William Cambridge,David H. Wilson,Michael H. Kagey,Walter Newman,Jeffrey W. Pollard,Luke Boulter	15
9	Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation 2021 ·Science Signaling ·(unknown),Sofía Ferreira-González,Niya Aleksieva,Tak Yung Man,Victoria L. Gadd,Michael J. Williams,Rachel V. Guest,Wei‐Yu Lu,Benjamin J. Dwyer,Thomas Jamieson,Colin Nixon,Noémi Van Hul,Frédéric P. Lemaigre,John McCafferty,Isabelle Leclercq,Owen J. Sansom,Luke Boulter,Stuart J. Forbes	26
10	Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation 2021 ·npj Regenerative Medicine ·Francesco Bellanti,(unknown),Giuseppina Iannelli,Giuseppe Pannone,Maria Carmela Pedicillo,Luke Boulter,Wei‐Yu Lu,Rosanna Tamborra,Rosanna Villani,Gianluigi Vendemiale,Stuart J. Forbes,Gaetano Serviddio	15
11	TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression 2020 ·Journal of Hepatology ·Benjamin J. Dwyer,Edward J. Jarman,Jully Gogoi-Tiwari,Sofía Ferreira-González,Luke Boulter,Rachel V. Guest,Timothy J. Kendall,Dominic Kurian,Alastair M. Kilpatrick,Andrew J. Robson,Eoghan O’Duibhir,Tak Yung Man,Lara Campana,Philip J. Starkey Lewis,Stephen J. Wigmore,John K. Olynyk,Grant A. Ramm,Janina E. E. Tirnitz‐Parker,Stuart J. Forbes	58
12	Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1 2019 ·Nature Communications ·Timothy J. Kendall,(unknown),Luke Boulter,David H. Wilson,(unknown),Stuart Aitken,Stuart J. Forbes,John P. Iredale,Nicholas D. Hastie	18
13	A Cell/Cilia Cycle Biosensor for Single-Cell Kinetics Reveals Persistence of Cilia after G1/S Transition Is a General Property in Cells and Mice 2018 ·Developmental Cell ·Matthew J. Ford,Patricia L. Yeyati,Girish R. Mali,Margaret Keighren,(unknown),Heidi K. Mjoseng,(unknown),Emma A. Hall,Asako Sakaue‐Sawano,Atsushi Miyawaki,Richard R. Meehan,Luke Boulter,Ian J. Jackson,Pleasantine Mill,Richard L. Mort	70
14	Paracrine cellular senescence exacerbates biliary injury and impairs regeneration 2018 ·Nature Communications ·Sofía Ferreira-González,Wei‐Yu Lu,Alexander Raven,Benjamin J. Dwyer,Tak Yung Man,Eoghan O’Duibhir,Philip J. Starkey Lewis,Lara Campana,Timothy J. Kendall,Thomas G. Bird,Núria Tarrats,Juan Carlos Acosta,Luke Boulter,Stuart J. Forbes	114
15	Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma 2017 ·npj Regenerative Medicine ·Rachel V. Guest,Luke Boulter,Benjamin J. Dwyer,Stuart J. Forbes	10
16	Hepatic progenitor cells of biliary origin with liver repopulation capacitybreakdown → 2015 ·Nature Cell Biology ·Wei‐Yu Lu,Thomas G. Bird,Luke Boulter,Atsunori Tsuchiya,Alicia M. Cole,Trevor Hay,Rachel V. Guest,Davina Wojtacha,Tak Yung Man,Alison C. MacKinnon,Rachel A. Ridgway,Timothy J. Kendall,Michael J. Williams,Thomas Jamieson,Alexander Raven,David C. Hay,John P. Iredale,Alan R. Clarke,Owen J. Sansom,Stuart J. Forbes	345
17	Cell Lineage Tracing Reveals a Biliary Origin of Intrahepatic Cholangiocarcinoma 2013 ·Cancer Research ·Rachel V. Guest,Luke Boulter,Timothy J. Kendall,(unknown),Robert Walker,Stephen J. Wigmore,Owen J. Sansom,Stuart J. Forbes	90
18	Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling 2013 ·Proceedings of the National Academy of Sciences ·Thomas G. Bird,Wei‐Yu Lu,Luke Boulter,Sabrina Gordon-Keylock,Rachel A. Ridgway,Michael J. Williams,(unknown),James A. Thomas,Davina Wojtacha,Adriana Rosa Gambardella,Owen J. Sansom,John P. Iredale,Stuart J. Forbes	132
19	Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver diseasebreakdown → 2012 ·Nature Medicine ·Luke Boulter,Olivier Govaere,Thomas G. Bird,Sorina Radulescu,Prakash Ramachandran,Antonella Pellicoro,Rachel A. Ridgway,Sang Soo Seo,Bart Spee,Nico van Rooijen,Owen J. Sansom,John P. Iredale,Sally Lowell,Tania Roskams,Stuart J. Forbes	582
20	OC-157 Physiological changes in matrix stiffness modulate hepatic progenitor cell morphology, proliferation and differentiation 2012 ·Gut ·Timothy T. Gordon‐Walker,J. Schrader,Luke Boulter,A. J. Robson,Stuart J. Forbes,Rebecca G. Wells,John P. Iredale	3

About Luke Boulter

Luke Boulter is a scholar working on Hepatology, Cancer Research and Surgery, having authored 48 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). The work is most often cited by research in Hepatology (1.8k citations), Surgery (1.5k citations) and Immunology (644 citations). Luke Boulter has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Stuart J. Forbes, John P. Iredale, Wei‐Yu Lu, Owen J. Sansom, Nico van Rooijen, Thomas G. Bird, Antonella Pellicoro, Prakash Ramachandran, Rachel A. Ridgway and Timothy J. Kendall. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact